Literature DB >> 30778739

Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.

Heidi Coy1, Kevin Hsieh2, Willie Wu3, Mahesh B Nagarajan4, Jonathan R Young5, Michael L Douek4, Matthew S Brown4, Fabien Scalzo6, Steven S Raman7.   

Abstract

PURPOSE: Currently, all solid enhancing renal masses without microscopic fat are considered malignant until proven otherwise and there is substantial overlap in the imaging findings of benign and malignant renal masses, particularly between clear cell RCC (ccRCC) and benign oncocytoma (ONC). Radiomics has attracted increased attention for its utility in pre-operative work-up on routine clinical images. Radiomics based approaches have converted medical images into mineable data and identified prognostic imaging signatures that machine learning algorithms can use to construct predictive models by learning the decision boundaries of the underlying data distribution. The TensorFlow™ framework from Google is a state-of-the-art open-source software library that can be used for training deep learning neural networks for performing machine learning tasks. The purpose of this study was to investigate the diagnostic value and feasibility of a deep learning-based renal lesion classifier using open-source Google TensorFlow™ Inception in differentiating ccRCC from ONC on routine four-phase MDCT in patients with pathologically confirmed renal masses.
METHODS: With institutional review board approval for this 1996 Health Insurance Portability and Accountability Act compliant retrospective study and a waiver of informed consent, we queried our institution's pathology, clinical, and radiology databases for histologically proven cases of ccRCC and ONC obtained between January 2000 and January 2016 scanned with a an intravenous contrast-enhanced four-phase renal mass protocol (unenhanced (UN), corticomedullary (CM), nephrographic (NP), and excretory (EX) phases). To extract features to be used for the machine learning model, the entire renal mass was contoured in the axial plane in each of the four phases, resulting in a 3D volume of interest (VOI) representative of the entire renal mass. We investigated thirteen different approaches to convert the acquired VOI data into a set of images that adequately represented each tumor which was used to train the final layer of the neural network model. Training was performed over 4000 iterations. In each iteration, 90% of the data were designated as training data and the remaining 10% served as validation data and a leave-one-out cross-validation scheme was implemented. Accuracy, sensitivity, specificity, positive (PPV) and negative predictive (NPV) values, and CIs were calculated for the classification of the thirteen processing modes.
RESULTS: We analyzed 179 consecutive patients with 179 lesions (128 ccRCC and 51 ONC). The ccRCC cohort had a mean size of 3.8 cm (range 0.8-14.6 cm) and the ONC cohort had a mean lesion size of 3.9 cm (range 1.0-13.1 cm). The highest specificity and PPV (52.9% and 80.3%, respectively) were achieved in the EX phase when we analyzed the single mid-slice of the tumor in the axial, coronal and sagittal plane, and when we increased the number of mid-slices of the tumor to three, with an accuracy of 75.4%, which also increased the sensitivity to 88.3% and the PPV to 79.6%. Using the entire tumor volume also showed that classification performance was best in the EX phase with an accuracy of 74.4%, a sensitivity of 85.8% and a PPV of 80.1%. When the entire tumor volume, plus mid-slices from all phases and all planes presented as tiled images, were submitted to the final layer of the neural network we achieved a PPV of 82.5%.
CONCLUSIONS: The best classification result was obtained in the EX phase among the thirteen classification methods tested. Our proof of concept study is the first step towards understanding the utility of machine learning in the differentiation of ccRCC from ONC on routine CT images. We hope this could lead to future investigation into the development of a multivariate machine learning model which may augment our ability to accurately predict renal lesion histology on imaging.

Entities:  

Keywords:  Clear cell renal cell carcinoma; Deep learning; Multiphasic CT; Oncocytoma; Radiogenomics; Radiomics

Year:  2019        PMID: 30778739     DOI: 10.1007/s00261-019-01929-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  13 in total

1.  Point Shear Wave Elastography Using Machine Learning to Differentiate Renal Cell Carcinoma and Angiomyolipoma.

Authors:  Hersh Sagreiya; Alireza Akhbardeh; Dandan Li; Rosa Sigrist; Benjamin I Chung; Geoffrey A Sonn; Lu Tian; Daniel L Rubin; Jürgen K Willmann
Journal:  Ultrasound Med Biol       Date:  2019-05-25       Impact factor: 2.998

Review 2.  Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study.

Authors:  Milap Shah; Nithesh Naik; Bhaskar K Somani; B M Zeeshan Hameed
Journal:  Turk J Urol       Date:  2020-05-27

3.  Importance of phase enhancement for machine learning classification of solid renal masses using texture analysis features at multi-phasic CT.

Authors:  Nicola Schieda; Kathleen Nguyen; Rebecca E Thornhill; Matthew D F McInnes; Mark Wu; Nick James
Journal:  Abdom Radiol (NY)       Date:  2020-07-05

4.  MR texture analysis in differentiating renal cell carcinoma from lipid-poor angiomyolipoma and oncocytoma.

Authors:  Abdul Razik; Ankur Goyal; Raju Sharma; Devasenathipathy Kandasamy; Amlesh Seth; Prasenjit Das; Balaji Ganeshan
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

5.  Deep learning based classification of solid lipid-poor contrast enhancing renal masses using contrast enhanced CT.

Authors:  Assad Oberai; Bino Varghese; Steven Cen; Tomas Angelini; Darryl Hwang; Inderbir Gill; Manju Aron; Christopher Lau; Vinay Duddalwar
Journal:  Br J Radiol       Date:  2020-05-11       Impact factor: 3.039

Review 6.  Deep Learning: A Review for the Radiation Oncologist.

Authors:  Luca Boldrini; Jean-Emmanuel Bibault; Carlotta Masciocchi; Yanting Shen; Martin-Immanuel Bittner
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

7.  Deep learning based prediction of prognosis in nonmetastatic clear cell renal cell carcinoma.

Authors:  Seok-Soo Byun; Tak Sung Heo; Jeong Myeong Choi; Yeong Seok Jeong; Yu Seop Kim; Won Ki Lee; Chulho Kim
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  A Reliable Prediction Model for Renal Cell Carcinoma Subtype Based on Radiomic Features from 3D Multiphase Enhanced CT Images.

Authors:  Haijie Zhang; Fu Yin; Menglin Chen; Anqi Qi; Zihao Lai; Liyang Yang; Ge Wen
Journal:  J Oncol       Date:  2021-09-21       Impact factor: 4.375

9.  A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma.

Authors:  Lu Yang; Long Gao; Dooman Arefan; Yuchuan Tan; Hanli Dan; Jiuquan Zhang
Journal:  BMC Med Imaging       Date:  2022-01-30       Impact factor: 1.930

10.  Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.

Authors:  Ruizhi Gao; Hui Qin; Peng Lin; Chenjun Ma; Chengyang Li; Rong Wen; Jing Huang; Da Wan; Dongyue Wen; Yiqiong Liang; Jiang Huang; Xin Li; Xinrong Wang; Gang Chen; Yun He; Hong Yang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.